GIPAM Welcomes New Leadership to Enhance Strategic Vision and Drive Growth
We are pleased to welcome Chiara Stella Cochetti and Dr Jason Simeone to GIPAM in their new appointments. Chiara joins us as Vice President of Commercial Operations, and Dr Simeone as Head of GIPAM US. Their extensive experience in healthcare data analytics, market research, and real-world evidence (RWE) will play a vital role in shaping our strategic direction and supporting our growth ambitions.
Chiara Stella Cochetti: Leading Commercial Strategy at GIPAM
Chiara Stella Cochetti brings over 15 years of experience in analytics and market research, with a strong background in leading sales and managing client portfolios at prominent healthcare consultancies, including IQVIA, Adelphi Values, and Cytel. In her new role as VP of Commercial Operations, Chiara will guide our commercial strategy, focusing on innovative solutions and creating measurable value for our clients.
Chiara's deep understanding of market dynamics and her strategic insight will be crucial in advancing GIPAM’s core platforms—OncoCase, Anchor, and EVIGATOR. These platforms are designed to drive long-term partnerships and foster sustainable growth by providing cutting-edge insights that help clients navigate complex market environments. Her leadership will help ensure that GIPAM continues to innovate in RWE and market access, delivering meaningful solutions that address the evolving needs of the healthcare industry.
Dr Jason Simeone: Expanding GIPAM’s Presence in the US Market
We are also excited to welcome Dr Jason Simeone as the Head of GIPAM US. With over 15 years of experience as a pharmacoepidemiologist, Dr Simeone has a strong track record of conducting real-world evidence studies across the United States, EU, and other global markets. His previous roles at Cytel and Evidera have provided him with extensive expertise in using claims, electronic medical records, surveys, and registry data to generate valuable evidence for regulatory and market access purposes.
With Dr Simeone’s appointment, GIPAM is expanding its presence in the US by offering comprehensive RWE support. This includes services in drug safety, comparative effectiveness, burden of illness studies, database feasibility and landscaping studies, and evidence synthesis activities. His leadership will be instrumental in enhancing our capabilities and delivering high-quality, data-driven insights tailored to the diverse needs of our clients.
Strategic Vision and Future Ambitions
The appointments of Chiara and Jason mark an exciting new chapter for GIPAM. Their combined expertise and leadership will enhance our service offerings and strengthen our strategic direction as we strive to grow and become a leader in healthcare analytics and market access. By expanding our capabilities and building our presence in key markets, we are committed to driving sustainable growth and delivering exceptional value to our clients.
We look forward to the positive impact Chiara and Jason will have on our team and our continued efforts to achieve our long-term goals. For more information on our expanded capabilities or to discuss your research needs, please contact us at rwe.experts@gipam-health.com.
Stay tuned for more updates as we continue to grow and pursue our ambitions at GIPAM!